Novo Nordisk to phase out human insulin pens: report
Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.
abp LIVE11h
India Accounts For 25% Of Adults With Diabetes, Over 70% Without Treatment: Lancet Study’s Alarming Findings
The study, backed by the WHO, was released to mark World Diabetes Day on Thursday. It conducts a comparison between the ...
Comparing Oral vs. Injectable Semaglutide: Is One More Effective Than the Other?
It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...
drugdeliverybusiness13h
The biggest diabetes tech stories of the year so far
On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.
Dean Kamen, insulin pump pioneer, wants to shake up diabetes tech
Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with a new kind of pump technology in the Twiist device.
medtechdive6d
Tandem, Insulet tout Type 2 expectations as tech attracts new users
Insulet saw strong insulin pump adoption among new users with Type 2 diabetes following its recent FDA clearance, while ...
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q3 2024 Earnings Call Transcript
Q3 2024 Earnings Call Transcript November 6, 2024 Tandem Diabetes Care, Inc. beats earnings expectations. Reported EPS is $-0 ...